0000899243-20-000995.txt : 20200110
0000899243-20-000995.hdr.sgml : 20200110
20200110181416
ACCESSION NUMBER: 0000899243-20-000995
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200108
FILED AS OF DATE: 20200110
DATE AS OF CHANGE: 20200110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McDonough John
CENTRAL INDEX KEY: 0001615937
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 20522147
MAIL ADDRESS:
STREET 1: T2 BIOSYSTEMS, INC.
STREET 2: 101 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-08
0
0001492674
T2 Biosystems, Inc.
TTOO
0001615937
McDonough John
101 HARTWELL AVE
LEXINGTON
MA
02421
1
0
0
0
Common Stock
2020-01-08
4
M
0
16666
A
470285
D
Common Stock
2020-01-08
4
M
0
100000
A
570285
D
Performance Restricted Stock Units
2020-01-08
4
D
0
326087
0.00
D
Common Stock
326087
0
D
Restricted Stock Units
2020-01-08
4
M
0
16666
0.00
D
Common Stock
16666
0
D
Restricted Stock Units
2020-01-08
4
M
0
100000
0.00
D
Common Stock
100000
0
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
Includes 5,399 shares acquired under the Issuer's employee stock purchase plan on May 15, 2019.
On March 15, 2018, the reporting person was granted Performance Restricted Stock Units that vest in the form of common stock based upon the achievement of certain pre-established 90-day average daily closing prices per share goals over a three year performance period. On January 8, 2020, the reporting person incurred a termination of service and forfeited the remaining unvested RSU's subject to this grant.
Pursuant to the terms of that certain Employment Agreement by and between the reporting person and Issuer, dated March 4, 2008, as amended by that certain First Amendment to Employment Agreement, dated July 7, 2014 and that certain Second Amendment to Employment Agreement, dated July 30, 2019, upon the reporting person's resignation as Chief Executive Officer, these RSUs automatically vested on January 8, 2020.
/s/ John Sprague, Attorney-in-fact
2020-01-10